Expert guidance for developing new pain therapies

MEDICINAL CHEMISTRY CONSULTING SERVICES

NIH-funded research · NIH-11042104

This study is all about helping scientists create better pain relief medicines by getting expert advice on how to improve their drug designs and development plans, all done through friendly online meetings and emails.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Project IDNIH-11042104 on NIH RePORTER

What this research studies

This research involves providing high-level medicinal chemistry consulting to support the development of new therapies for pain management. Experts will offer feedback on chemical structures and processes, evaluate data, and help strategize drug discovery and development projects. The consulting will occur through virtual meetings and email, ensuring that the NIH and its partners receive the necessary expertise to advance their projects effectively.

Who could benefit from this research

Good fit: Patients suffering from chronic pain conditions who may benefit from new therapeutic options.

Not a fit: Patients with acute pain or those who do not respond to conventional pain management strategies may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective pain management therapies.

How similar studies have performed: Similar approaches in medicinal chemistry consulting have shown success in advancing drug development projects, indicating a promising potential for this initiative.

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.